NEQAS - Ensuring Standards In Molecular Diagnostics
Dr Sandi Deans is a Consultant Clinical Scientist and the Director of UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics which is based in the Department of Laboratory Medicine, Royal Infirmary of Edinburgh. The UK NEQAS scheme delivers assessment of molecular genetic testing, molecular pathology testing, newborn screening, prenatal diagnosis, preimplantation genetic diagnosis and is involved in the new technical next generation sequencing scheme.
Sandi sits on many committees including the European Molecular Quality Network Board, UK NEQAS Steering Committees for Clinical Cytogenetics, Cellular Pathology Techniques and Molecular Genetics, and has recently been appointed as Board member and Treasurer of the International Quality Network for Pathology (IQN Path).
She is a past UK NEQAS Executive Director, Association of Clinical Genetic Science Executive Committee member and has been involved in the selection panels for MCADD extended mutation screening laboratories and the Cancer Research UK Stratified Medicine Technical Hub laboratories.
Sandi is currently working as the National Laboratory Lead for the NHS England 100,000 Genomes project implementation unit and collaborates closely with Genomics England to deliver high quality sequencing for both the rare diseases and cancer programmes.